Palomino Laboratories (PALX) Total Current Liabilities (2022 - 2025)

Palomino Laboratories' (PALX) quarterly Total Current Liabilities came in at $336458.0 in Q4 2025, up 5131.81% year-on-year from $6431.0 in Q4 2024, and down 66.32% quarter-over-quarter from $999013.0 in Q3 2025.

Palomino Laboratories (PALX) Total Current Liabilities (2022 - 2025) Analysis & Trends

Palomino Laboratories has disclosed Total Current Liabilities across 4 years of filings, most recently posting $336458.0 for Q4 2025.

  • Total Current Liabilities for Q4 2025 came in at $336458.0, up 5131.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $336458.0 (up 5131.81% YoY), and the FY2025 annual result was $336458.0, up 5131.81% from the prior year.
  • Total Current Liabilities came in at $336458.0 for Q4 2025 at Palomino Laboratories, down from $999013.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $6431.0 in Q4 2024.
  • The 4-year median for Total Current Liabilities is $194658.0 (2024), against an average of $258284.6.
  • Across the five-year window, Total Current Liabilities tumbled 94.24% in 2024 and soared 5131.81% in 2025, its largest moves.
  • Palomino Laboratories' Total Current Liabilities stood at $27804.0 in 2022, then surged by 301.46% to $111621.0 in 2023, then sank by 94.24% to $6431.0 in 2024, then jumped by 5131.81% to $336458.0 in 2025.
  • The last three Total Current Liabilities figures came in at $336458.0 (Q4 2025), $999013.0 (Q3 2025), and $364431.0 (Q2 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 336,458.00
Sep 30, 2025 999,013.00
Jun 30, 2025 364,431.00
Mar 31, 2025 336,989.00
Dec 31, 2024 6,431.00
Sep 30, 2024 221,754.00
Jun 30, 2024 194,658.00
Mar 31, 2024 162,925.00
Dec 31, 2023 111,621.00
Sep 30, 2023 79,047.00
Dec 31, 2022 27,804.00